| 产品名称 |
点击数 |
| Anti-Human HLA-DRB1 Recombinant Antibody, PerCP|抗人HLA-DRB1重组抗体，PerCP(靶标：人MHC II类HLA-DRB1) |
162 |
| Anti-Human HLA-DRB1 Recombinant Antibody, PerCP|抗人HLA-DRB1重组抗体，PerCP(靶标：人MHC II类HLA-DRB1) |
303 |
| Anti-Human HLA-DR10 (DRB1*1001) Recombinant Antibody , PerCP|抗人HLA-DR10（DRB1*1001）重组抗体，PerCP(靶标：人MHC II类HLA-DR10) |
145 |
| Anti-Human HLA-DP Monomorphic Recombinant Antibody , PerCP|抗人HLA-DP单态性重组抗体，PerCP(靶标：人MHC II类HLA-DP) |
456 |
| Anti-Human HLA-DQ Monomorphic Recombinant Antibody, PerCP|抗人HLA-DQ单态性重组抗体，PerCP(靶标：人MHC II类HLA-DQ) |
200 |
| Anti-Human HLA-DR Monomorphic Recombinant Antibody, PerCP|抗人HLA-DR单态性重组抗体，PerCP(靶标：人MHC II类HLA-DR) |
271 |
| Anti-Mouse H2-Ab1/MHCII Recombinant Antibody, PerCP|抗小鼠H2-Ab1/MHCII重组抗体，PerCP(靶标：小鼠MHC II类（H2-Ab1）) |
247 |
| Anti-Mouse H2-Ab1/MHCII Recombinant Antibody, PerCP|抗小鼠H2-Ab1/MHCII重组抗体，PerCP(靶标：小鼠MHC II类（H2-Ab1）) |
291 |
| Anti-Human ROBO4 Recombinant Antibody, PerCP|抗人ROBO4重组抗体，PerCP(靶标：人Roundabout受体4) |
210 |
| Anti-Human MUC4 Recombinant Antibody, PerCP|抗人MUC4重组抗体，PerCP(靶标：人黏蛋白4) |
437 |
| Anti-Human glyco-MUC4 Recombinant Antibody, PerCP|抗人glyco-MUC4重组抗体，PerCP(靶标：人糖基化黏蛋白4) |
280 |
| Anti-Human CD175/Tn Recombinant Antibody , PerCP|抗人CD175/Tn重组抗体，PerCP(靶标：Tn抗原) |
350 |
| Anti-Human Complement C5b-9 Complex Recombinant Antibody, PerCP|抗人补体C5b-9复合物重组抗体，PerCP(靶标：人补体膜攻击复合物（C5b-9）) |
407 |
| Anti-Human BTN2A1 Recombinant Antibody , PerCP|抗人BTN2A1重组抗体，PerCP(靶标：人嗜乳脂蛋白2A1) |
490 |
| Anti-Human BTN2A1/2 Recombinant Antibody , PerCP|抗人BTN2A1/2重组抗体，PerCP(靶标：人嗜乳脂蛋白2A1/2) |
331 |
| Anti-Human S1PR3 Recombinant Antibody, PerCP|抗人S1PR3重组抗体，PerCP(靶标：人鞘氨醇-1-磷酸受体3) |
448 |
| Anti-Human STEAP2 Recombinant Antibody , PerCP|抗人STEAP2重组抗体，PerCP(靶标：人前列腺六跨膜上皮抗原2) |
364 |
| Anti-Glycosaminoglycans/GAGs Recombinant Antibody , PerCP|抗糖胺聚糖/GAGs重组抗体，PerCP(靶标：糖胺聚糖) |
357 |
| Anti-Glycosaminoglycans/GAGs Recombinant Antibody , PerCP|抗糖胺聚糖/GAGs重组抗体，PerCP(靶标：糖胺聚糖) |
179 |
| Anti-Staphylococcus aureus Protein A/SPA Recombinant Antibody , PerCP|抗金黄色葡萄球菌蛋白A/SPA重组抗体，PerCP(靶标：金黄色葡萄球菌蛋白A) |
466 |
